Skip to main content

Table 3 Follow-up details

From: Evaluation of safety and efficacy of rapamycin-eluting balloon in patients with intracranial atherosclerotic stenosis: a cohort study

Clinical details

7 days (n = 79)

1 month (n = 78)

6 months (n = 78)

12 months (n = 78)

Recurrent clinical syndrome (% of total)

    

 Stroke

6 (7.5%)

0

0

0

 Transient ischemic attack (TIA)

1 (1.25%)

0

0

0

Time to follow-up imaging (months)

   

8.7 ± 2.0

 Mortality rate (% of total)

1 (1.25%)

1 (1.25%)

0

0

 Angiographic restenosis (% of total)

4 (5%)

0

0

0